Login

Kilitch Drugs (India) Ltd.

₹416.95

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Kilitch Drugs (India) Ltd.

  • NSE : KILITCH
Add Alert
Add Watchlist

₹416.95

₹416.95

-8.5 (-2.0%) - 18 Aug 2025 04:31 PM
  • NSE : KILITCH

About Company

Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms. The Company is a manufacturer of antibacterial parenteral formulations. Its products include Carbapenems, Cephalosporins, Aminoglycosides, anti malarials, and other anti-infectives. The Company trades in Eyekare Pharmaceuticals products and is located in Mumbai. On February 28, 2012, the Company discontinued its manufacturing activity at Paonta Sahib. The Company also transferred certain products by entering into a product transfer agreement with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.

Market Cap. ₹ 729 Cr.
52 Week - High/Low ₹ 500/294
P/E Ratio 23.47
P/B Ratio 3.49
Enterprise Value ₹ 799 Cr.
ROE % 8.51
RSI Value 36.11
EMA 50 435.51
EMA 200 388.32
Market Cap. ₹ 729 Cr.
52 Week - High/Low ₹ 500/294
P/E Ratio 27.78
P/B Ratio 4.41
Enterprise Value ₹ 796 Cr.
ROE % 8.43
RSI Value 36.11
EMA 50 435.51
EMA 200 388.32
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.